BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24911644)

  • 1. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.
    Seillier A; Dominguez Aguilar D; Giuffrida A
    Pharmacol Biochem Behav; 2014 Sep; 124():153-9. PubMed ID: 24911644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
    Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.
    Fucich EA; Stielper ZF; Cancienne HL; Edwards S; Gilpin NW; Molina PE; Middleton JW
    J Neurophysiol; 2020 Feb; 123(2):707-717. PubMed ID: 31913777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
    Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.
    Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A
    Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
    Muldoon PP; Chen J; Harenza JL; Abdullah RA; Sim-Selley LJ; Cravatt BF; Miles MF; Chen X; Lichtman AH; Damaj MI
    Br J Pharmacol; 2015 Feb; 172(3):869-82. PubMed ID: 25258021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.
    Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A
    Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress-related behaviour and drinking in Marchigian Sardinian alcohol-preferring rats.
    Vozella V; Cruz B; Feldman HC; Bullard R; Bianchi PC; Natividad LA; Cravatt BF; Zorrilla EP; Ciccocioppo R; Roberto M
    Br J Pharmacol; 2023 Dec; 180(24):3130-3145. PubMed ID: 37488777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease.
    Kanwal H; Sangineto M; Ciarnelli M; Castaldo P; Villani R; Romano AD; Serviddio G; Cassano T
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system as a target for novel anxiolytic drugs.
    Patel S; Hill MN; Cheer JF; Wotjak CT; Holmes A
    Neurosci Biobehav Rev; 2017 May; 76(Pt A):56-66. PubMed ID: 28434588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
    Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
    J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK; Drew GM; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.
    Zhang Z; Wang W; Zhong P; Liu SJ; Long JZ; Zhao L; Gao HQ; Cravatt BF; Liu QS
    Hippocampus; 2015 Jan; 25(1):16-26. PubMed ID: 25131612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
    Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
    Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model.
    Adamson Barnes NS; Mitchell VA; Kazantzis NP; Vaughan CW
    Br J Pharmacol; 2016 Jan; 173(1):77-87. PubMed ID: 26398331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.
    Turcotte C; Chouinard F; Lefebvre JS; Flamand N
    J Leukoc Biol; 2015 Jun; 97(6):1049-70. PubMed ID: 25877930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons.
    Baggelaar MP; Chameau PJ; Kantae V; Hummel J; Hsu KL; Janssen F; van der Wel T; Soethoudt M; Deng H; den Dulk H; Allarà M; Florea BI; Di Marzo V; Wadman WJ; Kruse CG; Overkleeft HS; Hankemeier T; Werkman TR; Cravatt BF; van der Stelt M
    J Am Chem Soc; 2015 Jul; 137(27):8851-7. PubMed ID: 26083464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.